Circulating Biomarker Market Report

Global and China Circulating Biomarker Industry Market Research Report (2017-2028)

  • POSTDATE：Oct 31, 2022
  • PAGES：230
  • REPORT CODE：GMM1332689
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Circulating Biomarker industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Trovagene (US)

    • MDxHealth SA (US)

    • Fraunhofer-Gesellschaft (Germany)

    • Guardant Health (US)

    • Myriad Genetics (US)

    • Biocept Inc (US)

    • Janssen Diagnostics (US)

    • Bio-Rad Laboratories (US)

    • QIAGEN (Netherlands)

    • Roche (Switzerland)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Lung

    • Breast

    • Colorectal

    • Prostate

    Application:

    • Reference Laboratory

    • Research Centers

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Circulating Biomarker Industry Overview

      • 1.1.1 Circulating Biomarker Market Scope and Market Segments

      • 1.1.2 Circulating Biomarker Industry Characteristics

      • 1.1.3 Global and China Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Circulating Biomarker Production Value and Growth Rate (2017-2028)

    • 1.2 Global Circulating Biomarker Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Lung

      • 1.2.2 Breast

      • 1.2.3 Colorectal

      • 1.2.4 Prostate

    • 1.3 Global Circulating Biomarker Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Reference Laboratory

      • 1.3.2 Research Centers

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Circulating Biomarker Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Circulating Biomarker Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Circulating Biomarker Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Circulating Biomarker Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Circulating Biomarker Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Circulating Biomarker Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Circulating Biomarker Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Circulating Biomarker Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Circulating Biomarker Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Circulating Biomarker Industry Porter's Five Forces Model Analysis

      • 2.2.3 Circulating Biomarker Industry PEST Analysis

    • 2.3 Circulating Biomarker Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Circulating Biomarker Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Circulating Biomarker Industry

    Chapter 3 Global and China Circulating Biomarker Market, by Manufacturer

    • 3.1 Global and China Circulating Biomarker Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Circulating Biomarker Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Circulating Biomarker Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Circulating Biomarker Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Circulating Biomarker Market Top 3 Players

    Chapter 4 Global and China Circulating Biomarker Market, by Type (2017-2028)

    • 4.1 Circulating Biomarker Market Trend, by Type

    • 4.2 Global Circulating Biomarker Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Circulating Biomarker Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Circulating Biomarker Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Circulating Biomarker Price Trend, by Type (2017-2028)

    • 4.3 China Circulating Biomarker Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Circulating Biomarker Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Circulating Biomarker Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Circulating Biomarker Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Circulating Biomarker Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Circulating Biomarker Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Circulating Biomarker Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Circulating Biomarker Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Circulating Biomarker Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Circulating Biomarker Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Circulating Biomarker Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Circulating Biomarker Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Circulating Biomarker Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Circulating Biomarker Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Circulating Biomarker Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Circulating Biomarker Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Circulating Biomarker Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Circulating Biomarker Market Analysis

    • 7.1 North America Circulating Biomarker Market, by Type

    • 7.2 North America Circulating Biomarker Market, by Application

    • 7.3 North America Circulating Biomarker Market Analysis and Forecast, by Country

      • 7.3.1 United States Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Circulating Biomarker Market Analysis

    • 8.1 Europe Circulating Biomarker Market, by Type

    • 8.2 Europe Circulating Biomarker Market, by Application

    • 8.3 Europe Circulating Biomarker Market Analysis and Forecast, by Country

      • 8.3.1 Germany Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Circulating Biomarker Market Analysis

    • 9.1 APAC Circulating Biomarker Market, by Type

    • 9.2 APAC Circulating Biomarker Market, by Application

    • 9.3 APAC Circulating Biomarker Market Analysis and Forecast, by Country

      • 9.3.1 China Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Circulating Biomarker Market Analysis

    • 10.1 Latin America, Middle East and Africa Circulating Biomarker Market, by Type

    • 10.2 Latin America, Middle East and Africa Circulating Biomarker Market, by Application

    • 10.3 Latin America, Middle East and Africa Circulating Biomarker Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Circulating Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Circulating Biomarker Company Profiles

      • 11.1 Trovagene (US)

        • 11.1.1 Trovagene (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Trovagene (US) Circulating Biomarker Product Profiles, Application and Specification

        • 11.1.3 Trovagene (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 MDxHealth SA (US)

        • 11.2.1 MDxHealth SA (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 MDxHealth SA (US) Circulating Biomarker Product Profiles, Application and Specification

        • 11.2.3 MDxHealth SA (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Fraunhofer-Gesellschaft (Germany)

        • 11.3.1 Fraunhofer-Gesellschaft (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Product Profiles, Application and Specification

        • 11.3.3 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Guardant Health (US)

        • 11.4.1 Guardant Health (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Guardant Health (US) Circulating Biomarker Product Profiles, Application and Specification

        • 11.4.3 Guardant Health (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Myriad Genetics (US)

        • 11.5.1 Myriad Genetics (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Myriad Genetics (US) Circulating Biomarker Product Profiles, Application and Specification

        • 11.5.3 Myriad Genetics (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Biocept Inc (US)

        • 11.6.1 Biocept Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Biocept Inc (US) Circulating Biomarker Product Profiles, Application and Specification

        • 11.6.3 Biocept Inc (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Janssen Diagnostics (US)

        • 11.7.1 Janssen Diagnostics (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Janssen Diagnostics (US) Circulating Biomarker Product Profiles, Application and Specification

        • 11.7.3 Janssen Diagnostics (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Bio-Rad Laboratories (US)

        • 11.8.1 Bio-Rad Laboratories (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Bio-Rad Laboratories (US) Circulating Biomarker Product Profiles, Application and Specification

        • 11.8.3 Bio-Rad Laboratories (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 QIAGEN (Netherlands)

        • 11.9.1 QIAGEN (Netherlands) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 QIAGEN (Netherlands) Circulating Biomarker Product Profiles, Application and Specification

        • 11.9.3 QIAGEN (Netherlands) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Roche (Switzerland)

        • 11.10.1 Roche (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Roche (Switzerland) Circulating Biomarker Product Profiles, Application and Specification

        • 11.10.3 Roche (Switzerland) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Circulating Biomarker Industry Investment Prospect and Risk Assessment

    • 12.1 Circulating Biomarker Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Circulating Biomarker Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure China Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Global Circulating Biomarker Production Value and Growth Rate (2017-2028)

    • Figure China Circulating Biomarker Production Value and Growth Rate (2017-2028)

    • Figure Global Circulating Biomarker Market Size and Growth Rate of Lung (2017-2028)

    • Figure Global Circulating Biomarker Market Size and Growth Rate of Breast (2017-2028)

    • Figure Global Circulating Biomarker Market Size and Growth Rate of Colorectal (2017-2028)

    • Figure Global Circulating Biomarker Market Size and Growth Rate of Prostate (2017-2028)

    • Figure Global Circulating Biomarker Market Size and Growth Rate of Reference Laboratory (2017-2028)

    • Figure Global Circulating Biomarker Market Size and Growth Rate of Research Centers (2017-2028)

    • Figure North America Circulating Biomarker Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Circulating Biomarker Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Circulating Biomarker Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Circulating Biomarker Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Circulating Biomarker Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Circulating Biomarker Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Circulating Biomarker Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Circulating Biomarker Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Circulating Biomarker Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Circulating Biomarker Market Share, by Manufacturer in 2021

    • Figure Global and China Circulating Biomarker Market Share, by Manufacturer in 2022

    • Table Global Circulating Biomarker Sales Volume, by Type (2017-2028)

    • Table Global Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure Global Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Table Global Circulating Biomarker Sales Value, by Type (2017-2028)

    • Table Global Circulating Biomarker Sales Value Share, by Type (2017-2028)

    • Figure Global Circulating Biomarker Price Trend, by Type (2017-2028)

    • Table China Circulating Biomarker Sales Volume, by Type (2017-2028)

    • Table China Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure China Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Table China Circulating Biomarker Sales Value, by Type (2017-2028)

    • Table China Circulating Biomarker Sales Value Share, by Type (2017-2028)

    • Figure China Circulating Biomarker Price Trend, by Type (2017-2028)

    • Table Global Circulating Biomarker Sales Volume, by Application (2017-2028)

    • Table Global Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure Global Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Table Global Circulating Biomarker Sales Value, by Application (2017-2028)

    • Table Global Circulating Biomarker Sales Value Share, by Application (2017-2028)

    • Figure Global Circulating Biomarker Sales Value Share, by Application (2017-2028)

    • Table China Circulating Biomarker Sales Volume, by Application (2017-2028)

    • Table China Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure China Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Table China Circulating Biomarker Sales Value, by Application (2017-2028)

    • Table China Circulating Biomarker Sales Value Share, by Application (2017-2028)

    • Figure China Circulating Biomarker Sales Value Share, by Application (2017-2028)

    • Figure China Circulating Biomarker Production, Import, Consumption and Export (2017-2022)

    • Figure North America Circulating Biomarker Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Circulating Biomarker Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Circulating Biomarker Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Circulating Biomarker Production, Import, Consumption and Export (2017-2022)

    • Table North America Circulating Biomarker Sales Volume, by Type (2017-2028)

    • Table North America Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure North America Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Table North America Circulating Biomarker Sales Volume, by Application (2017-2028)

    • Table North America Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure North America Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure United States Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure United States Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Canada Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Table Europe Circulating Biomarker Sales Volume, by Type (2017-2028)

    • Table Europe Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure Europe Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Table Europe Circulating Biomarker Sales Volume, by Application (2017-2028)

    • Table Europe Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure Europe Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure Germany Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure UK Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure UK Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure France Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure France Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Italy Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Spain Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Poland Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Russia Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Table APAC Circulating Biomarker Sales Volume, by Type (2017-2028)

    • Table APAC Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure APAC Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Table APAC Circulating Biomarker Sales Volume, by Application (2017-2028)

    • Table APAC Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure APAC Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure China Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure China Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Japan Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure India Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure India Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Circulating Biomarker Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Circulating Biomarker Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Circulating Biomarker Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Circulating Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Circulating Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Circulating Biomarker Sales Value and Growth Rate (2017-2028)

    • Table Trovagene (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Trovagene (US) Product Profiles, Application and Specification

    • Table Trovagene (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table MDxHealth SA (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table MDxHealth SA (US) Product Profiles, Application and Specification

    • Table MDxHealth SA (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fraunhofer-Gesellschaft (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fraunhofer-Gesellschaft (Germany) Product Profiles, Application and Specification

    • Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Guardant Health (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Guardant Health (US) Product Profiles, Application and Specification

    • Table Guardant Health (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Myriad Genetics (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Myriad Genetics (US) Product Profiles, Application and Specification

    • Table Myriad Genetics (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biocept Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biocept Inc (US) Product Profiles, Application and Specification

    • Table Biocept Inc (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Janssen Diagnostics (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Janssen Diagnostics (US) Product Profiles, Application and Specification

    • Table Janssen Diagnostics (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bio-Rad Laboratories (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bio-Rad Laboratories (US) Product Profiles, Application and Specification

    • Table Bio-Rad Laboratories (US) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table QIAGEN (Netherlands) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table QIAGEN (Netherlands) Product Profiles, Application and Specification

    • Table QIAGEN (Netherlands) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche (Switzerland) Product Profiles, Application and Specification

    • Table Roche (Switzerland) Circulating Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US